Oluwaseun Mary Ogunbajo, CRNP

Oluwaseun Ogunbajo practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Oluwaseun Ogunbajo's NPI, 1215650619, was assigned on September 21, 2022. Oluwaseun Ogunbajo holds Maryland license R193854.

Oluwaseun Ogunbajo's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Oluwaseun Ogunbajo's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Oluwaseun Ogunbajo is also affiliated with University of Maryland Rehabilitation & Orthopaedic Institute. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Oluwaseun Ogunbajo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Oluwaseun Ogunbajo practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Oluwaseun Ogunbajo's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Oluwaseun Ogunbajo is licensed in Maryland.

CMS counts 52 Medicare patients who saw Oluwaseun Ogunbajo in 2024. 60% of them have high cholesterol, and 54% have high blood pressure. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Oluwaseun Ogunbajo's median patient age at 39, with 42% women.

In 2024, Oluwaseun Ogunbajo wrote 717 Medicare Part D claims for 67 patients. 84% of them were for generic drugs.

Oluwaseun Ogunbajo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Oluwaseun Ogunbajo as offering telehealth.

CMS Open Payments shows 1 general payment to Oluwaseun Ogunbajo from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Neurelis, Inc. paid the most, $42.